Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2020-06-19 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Fermenta Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on June 29, 2020, inter alia:1. To consider and approve the ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchange (BSE Limited) informing about an upcoming Board Meeting scheduled for June 29, 2020. The agenda includes consideration and approval of audited financial statements for the quarter and financial year ended March 31, 2020, and recommendation of final equity dividend. It also mentions the closure of the trading window in compliance with SEBI regulations. The document is a formal announcement about the meeting and trading window closure, not the financial report itself. The document length is 2715 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice rather than a full Annual Report, Earnings Release, or Board/Management Information filing.
2020-06-19 English
Pursuant to Regulation 29 of SEBI LODR, 2015, we hereby inform you that meeting of the Board of Directors of the Company is scheduled to be held on Monday, June 29, 2020. Pursuant to our ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to the stock exchange (BSE Limited) informing about an upcoming Board Meeting scheduled for June 29, 2020. The agenda includes consideration and approval of audited financial statements for the quarter and financial year ended March 31, 2020, and recommendation of final equity dividend. It also mentions the closure of the trading window in compliance with SEBI regulations. The document is a formal announcement about the meeting and trading window closure, not the financial report itself. The document length is 2715 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement that does not fit into other specific categories like Annual Report or Interim Report.
2020-06-19 English
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a notice dated June 19, 2020, addressed to BSE Limited, informing about a scheduled Board Meeting on June 29, 2020. The agenda includes consideration and approval of audited financial statements for the quarter and financial year ended March 31, 2020, and recommendation of final equity dividend. It also mentions the closure of the trading window in compliance with SEBI regulations. The document is a formal announcement about an upcoming board meeting and trading window closure, not the financial report itself. The document length is 2715 characters, which is relatively short and consistent with a notice rather than a full report. Therefore, this document fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement and compliance notice, not an Annual Report or Earnings Release.
2020-06-19 English
Intimation of Revised Investor Relations Presentation With reference and further to our intimation dated June 8, 2020 filed with BSE Limited regarding 'Intimation of Investor Related ....
Regulatory Filings
2020-06-09 English
Intimation of Investor Relations Presentation Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy ....
Regulatory Filings
2020-06-08 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Disclosure relating to impact of CoVID-19 pandemic ....
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing an update on the impact of the COVID-19 pandemic on the company's operations. It references prior intimations and provides operational and financial impact details but does not contain comprehensive financial statements or detailed financial analysis. The document is an update on a material event affecting the company, consistent with a regulatory announcement under SEBI Listing Regulations. It is not a full financial report, earnings release, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-06-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.